As of 2026-02-07, the Relative Valuation of Prometheus Biosciences Inc (RXDX) is (56.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 199.92 USD, the upside of Prometheus Biosciences Inc based on Relative Valuation is -128.3%.
The range of the Relative Valuation is (56.87) - (57.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 18.2x | 18.2x |
| Forward P/E multiples | 17.5x - 18.1x | 17.8x |
| Fair Price | (56.87) - (57.00) | (56.60) |
| Upside | -128.4% - -128.5% | -128.3% |
| Date | P/E |